Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease
Our study highlights the potential benefits of long-term anticoagulation/antiplatelet therapy in hospitalized IBD patients, with improved mortality outcomes and healthcare utilization. While concerns regarding gastrointestinal bleeding exist, the overall safety profile suggests a role for these agents in mitigating thromboembolic risks without exacerbating disease severity. Further research is needed to look at optimal treatment strategies and addressing limitations to guide clinical decision-making in this population.
Authors
- Nishit Patel (ORCID: https://orcid.org/0000-0003-1364-0587)
- Janak Bahirwani (ORCID: https://orcid.org/0000-0002-9150-521X)
- Rahul Thakur (ORCID: https://orcid.org/0000-0003-1740-5939)
- Krishna Bodrya (ORCID: https://orcid.org/0000-0002-2252-6455)
- S. Ahuja (ORCID: https://orcid.org/0009-0003-2678-9935)
- Sanket Basida
- Sagar Pandey (ORCID: https://orcid.org/0000-0002-7791-8675)
- Yecheskel Schneider (ORCID: https://orcid.org/0000-0002-0680-3627)
- Madhav Changela (ORCID: https://orcid.org/0009-0002-5943-3372)
- Anish Shah
- Maulik Kaneriya
Institutions
- University of Missouri (US)
Publication Details
- Journal
- World Journal of Gastrointestinal Pharmacology and Therapeutics
- Published
- 2024-10-24
- DOI
- https://doi.org/10.4292/wjgpt.v15.i6.95532
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.55